I'm not that familiar with their previous financing arrangements with Aspire. It could be that additional financing is already pre-arranged and CTIX can just get the money when they want, but it's generally not a great idea for a bio stock to let the cash get this low.
I have no position in the company and am just following it loosely to see what happens with the defensin mimetics platform. After Polymedix's icy brush with bankruptcy, I figure these bio stocks are best left in the 'entertainment' category, lol.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.